.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Federal Trade Commission
Argus Health
Fuji
Farmers Insurance
Express Scripts
Mallinckrodt
Daiichi Sankyo
Johnson and Johnson
Colorcon

Generated: June 26, 2017

DrugPatentWatch Database Preview

Anastrozole - Generic Drug Details

« Back to Dashboard

What are the generic sources for anastrozole and what is the scope of anastrozole patent protection?

Anastrozole
is the generic ingredient in two branded drugs marketed by Sandoz, Natco Pharma Ltd, Zydus Pharms Usa Inc, Synthon Pharms, Kremers Urban Pharms, Dr Reddys Labs Ltd, Astrazeneca Pharms, Impax Labs Inc, Santos Biotech, Mylan, Apotex Inc, Teva Pharms, Cipla Ltd, Accord Hlthcare, Sun Pharm Inds Ltd, Watson Labs Teva, West-ward Pharms Int, and Fresenius Kabi Oncol, and is included in eighteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for anastrozole. Thirty-two suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: anastrozole

Tradenames:2
Patents:1
Applicants:18
NDAs:18
Drug Master File Entries: see list24
Suppliers / Packagers: see list32
Bulk Api Vendors: see list86
Clinical Trials: see list196
Patent Applications: see list6,552
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:anastrozole at DailyMed

Pharmacology for Ingredient: anastrozole

Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors

Tentative approvals for ANASTROZOLE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe1MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
ANASTROZOLE
anastrozole
TABLET;ORAL200654-001May 11, 2012ABRXNoNo► Subscribe► Subscribe
Zydus Pharms Usa Inc
ANASTROZOLE
anastrozole
TABLET;ORAL078921-001Jun 28, 2010ABRXNoNo► Subscribe► Subscribe
Sandoz
ANASTROZOLE
anastrozole
TABLET;ORAL079007-001Jun 28, 2010DISCNNoNo► Subscribe► Subscribe
Mylan
ANASTROZOLE
anastrozole
TABLET;ORAL091051-001Jun 28, 2010ABRXNoNo► Subscribe► Subscribe
Fresenius Kabi Oncol
ANASTROZOLE
anastrozole
TABLET;ORAL090088-001Jun 28, 2010ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: anastrozole

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms
ARIMIDEX
anastrozole
TABLET;ORAL020541-001Dec 27, 19954,935,437► Subscribe
Astrazeneca Pharms
ARIMIDEX
anastrozole
TABLET;ORAL020541-001Dec 27, 1995RE36617*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Farmers Insurance
Harvard Business School
Covington
Cantor Fitzgerald
Medtronic
McKesson
Fish and Richardson
Cipla
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot